Cilfa Opposition, Cannabinoid, (Ar113749 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, osimertinib, (AR115019A2)
Countries: Argentina Date: 2021
-
CILFA opposition, vinorelbine, (AR107829A1)
Countries: Argentina Date: 2018
-
CILFA opposition, LSD1 inhibitor, (AR107871A1)
Countries: Argentina Date: 2018
-
CILFA opposition, PI3K delta INHIBITORS, (AR100619A1)
Countries: Argentina Date: 2017
-
CILFA opposition, estetrol/drospirenone, (AR114357A1)
Countries: Argentina Date: 2020
-
CILFA opposition, bempedoic acid, (AR114396A1)
Countries: Argentina Date: 2020
-
CILFA opposition, estetrol, (AR114799A1)
Countries: Argentina Date: 2020
-
CILFA opposition, estetrol, (AR114798A1)
Countries: Argentina Date: 2020
-
CILFA opposition, trometamine/tramadol, (AR114006A1)
Countries: Argentina Date: 2020
-
CILFA opposition, valbenazine, (AR112819A1)
Countries: Argentina Date: 2020